Medica Group PLC
Director / PDMR Shareholding
Medica Group PLC (the "Company") announces that on 28 April 2023, the PDMRs listed below were granted options over ordinary shares of 0.2p each in the Company under the Company's Deferred Bonus Plan 2017 at a nil exercise price:
Name of PDMR |
Number of shares subject to option |
|
Stuart Quin |
|
21,418 |
Richard Jones |
|
15,119 |
Kevin Terrins |
|
10,546 |
Sarah Burns |
|
3,846 |
Marc O'Brien Caroline Byrne Rob Lavis Fiona Carr |
|
11,339 32,429 10,385 5,725 |
The notifications set out below are provided in accordance with the requirements of the UK Market Abuse Regulation, and set out more details of the transactions.
1. |
Details of PDMR |
|
(a) |
Name |
1. Stuart Quin 2. Richard Jones 3. Kevin Terrins 4. Sarah Burns 5. Marc O'Brien 6. Caroline Byrne 7. Rob Lavis 8. Fiona Carr
|
2. |
Reason for notification |
|
(b) |
Position / status |
1. Chief Executive Officer 2. Chief Financial Officer 3. Group Director of Corporate Development 4. Managing Director, UK 5. Chief Information Officer 6. Managing Director, Ireland 7. Group Medical Director 8. Group Head of Human Resources
|
|
Initial notification / amendment |
Initial notification in each case |
3. |
Details of the Issuer |
|
(a) |
Name |
Medica Group PLC |
(b) |
LEI |
213800B8XE5FUSZF5Z16 |
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted |
|
(a) |
Description of the financial instrument |
Ordinary shares of 0.2p each in the capital of the Company ("Shares") |
(b) |
Nature of the transaction |
Grant of options to acquire Shares pursuant to the Company's Deferred Bonus Plan 2017 |
(c) |
Price(s) and volume |
Option Price nil in each case 1. 21,418 2. 15,119 3. 10,546 4. 3,846 5. 11,339 6. 32,429 7. 10,385 8. 5,725
|
(d) |
Aggregated information |
N/A |
(e) |
Date of the transaction |
28 April 2023 |
(f) |
Place of the transaction |
Outside a trading venue |